Ask AI
ProCE Banner Activity

Managing Tardive Dyskinesia in Mood Disorders: Evidence-Based Approaches for Patients on Antipsychotic Therapy

Slideset

With the expanding use of antipsychotic agents for the treatment of bipolar and major depressive disorder, awareness of the risk for tardive dyskinesia is vital in these patient populations. This downloadable slideset presents best practices for screening, symptom assessment, and treatment with VMAT2 inhibitors.

Released: September 02, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Neurocrine Biosciences.

Neurocrine Biosciences